Florida
|
59-2971472
|
(State
or other jurisdiction of
|
I.R.S.
Employer ID No.
|
incorporation
or organization)
|
Large accelerated filer o |
Accelerated
filer x
|
Non-accelerated
filer o
|
September
30,
|
December
31,
|
||||||
2006
|
2005
|
||||||
CURRENT
ASSETS:
|
|||||||
Cash
and cash equivalents
|
$
|
17,301,540
|
$
|
10,273,635
|
|||
Short-term
investments
|
-
|
295,555
|
|||||
Accounts
receivable, net of allowance for doubtful accounts of
$4,856 at December 31, 2005
|
-
|
14,854
|
|||||
Prepaid
expenses
|
676,790
|
1,373,695
|
|||||
Other
current assets
|
218,843
|
307,205
|
|||||
Total
current assets
|
18,197,173
|
12,264,944
|
|||||
PROPERTY
AND EQUIPMENT, net
|
2,202,262
|
1,867,884
|
|||||
OTHER
ASSETS, net
|
10,074,005
|
9,698,802
|
|||||
Total
assets
|
$
|
30,473,440
|
$
|
23,831,630
|
|||
CURRENT
LIABILITIES:
|
|||||||
Accounts
payable
|
$
|
433,982
|
$
|
446,953
|
|||
Accrued
expenses:
Salaries
and wages
|
784,386
|
405,701
|
|||||
Professional
fees
|
293,969
|
287,667
|
|||||
Other
accrued expenses
|
364,350
|
286,562
|
|||||
Total
current liabilities
|
1,876,687
|
1,426,883
|
|||||
DEFERRED
RENT
|
516,747
|
5,163
|
|||||
Total
liabilities
|
2,393,434
|
1,432,046
|
|||||
COMMITMENTS
AND CONTINGENCIES (Notes 5 and 9)
|
|||||||
SHAREHOLDERS'
EQUITY:
|
|||||||
Common
stock, $.01 par value, 100,000,000 shares authorized,
23,372,227 and 20,958,765 shares issued and
outstanding at
|
|
|
|||||
September
30, 2006 and December 31, 2005,
respectively
|
233,722 |
209,588
|
|||||
Warrants
outstanding
|
20,290,878
|
17,693,482
|
|||||
Additional
paid-in capital
|
153,588,514
|
138,080,663
|
|||||
Accumulated
other comprehensive loss
|
-
|
(1,006
|
)
|
||||
Accumulated
deficit
|
(146,033,108
|
)
|
(133,583,143
|
)
|
|||
Total
shareholders' equity
|
28,080,006
|
22,399,584
|
|||||
Total
liabilities and shareholders' equity
|
$
|
30,473,440
|
$
|
23,831,630
|
Three
months ended
September
30,
|
Nine
months ended
September
30,
|
||||||||||||
2006
|
2005
|
2006
|
2005
|
||||||||||
Product
revenue
|
$
|
-
|
$
|
430,135
|
$
|
-
|
$
|
724,514
|
|||||
Cost
of goods sold
|
-
|
338,669
|
-
|
734,184
|
|||||||||
Write
down of inventory to net realizable
value
|
-
|
-
|
-
|
2,250,586
|
|||||||||
Gross
margin
|
-
|
91,466
|
-
|
(2,260,256
|
)
|
||||||||
Research
and development expenses
|
2,273,264
|
2,187,921
|
7,361,191
|
8,301,855
|
|||||||||
Marketing
and selling expenses
|
513,956
|
561,761
|
1,590,715
|
2,834,399
|
|||||||||
General
and administrative expenses
|
1,265,155
|
1,387,480
|
4,205,434
|
4,721,437
|
|||||||||
Impairment
loss and (gain) on disposal
of property and equipment
|
(7,251
|
)
|
(5,658
|
)
|
(7,251
|
)
|
1,874,110
|
||||||
Total
operating expenses
|
4,045,124
|
4,131,504
|
13,150,089
|
17,731,801
|
|||||||||
Interest
and other income
|
257,956
|
138,378
|
700,124
|
394,986
|
|||||||||
Net
loss
|
(3,787,168
|
)
|
(3,901,660
|
)
|
(12,449,965
|
)
|
(19,597,071
|
)
|
|||||
Unrealized
gain (loss) on securities
|
-
|
297
|
1,006
|
(2,672
|
)
|
||||||||
Comprehensive
loss
|
$
|
(3,787,168
|
)
|
$
|
(3,901,363
|
)
|
$
|
(12,448,959
|
)
|
$
|
(19,599,743
|
)
|
|
Basic
and diluted net loss per common
share
|
$
|
(0.16
|
)
|
$
|
(0.19
|
)
|
$
|
(0.54
|
)
|
$
|
(0.97
|
)
|
Three
Months Ended
September
30,
|
Nine
Months Ended
September
30,
|
||||||||||||
2006
|
2005
|
2006
|
2005
|
||||||||||
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|||||||||||||
Net
loss
|
$
|
(3,787,168
|
)
|
$
|
(3,901,660
|
)
|
$
|
(12,449,965
|
)
|
$
|
(19,597,071
|
)
|
|
Adjustments
to reconcile net loss to net cash used in
operating
activities:
|
|||||||||||||
Depreciation
and amortization
|
422,395
|
443,242
|
1,286,070
|
2,029,594
|
|||||||||
Amortization
of discounts on investments
|
-
|
7,257
|
1,561
|
22,092
|
|||||||||
Provision
for obsolete inventories
|
-
|
-
|
-
|
67,940
|
|||||||||
Write-down
of inventory to net realizable value
|
-
|
-
|
-
|
2,250,586
|
|||||||||
Impairment
loss on other assets
|
-
|
-
|
-
|
1,245,792
|
|||||||||
Stock
compensation
|
435,600
|
229,150
|
1,921,873
|
658,300
|
|||||||||
(Gain)
loss on disposal and impairment of equipment
|
(7,251
|
)
|
(5,658
|
)
|
(7,251
|
)
|
628,746
|
||||||
Changes
in operating assets and liabilities:
|
|||||||||||||
Accounts
receivable, net
|
-
|
94,929
|
14,854
|
282,484
|
|||||||||
Inventories
|
-
|
250,630
|
-
|
154,198
|
|||||||||
Prepaid
expenses and other assets
|
103,913
|
4,414
|
424,428
|
1,489,047
|
|||||||||
Accounts payable and accrued expenses
|
(157,580
|
)
|
(326,692
|
)
|
556,469
|
(785,482
|
)
|
||||||
Deferred
revenue
|
-
|
(535,481
|
)
|
-
|
(112,339
|
)
|
|||||||
Deferred
rent
|
50,719
|
(1,291
|
)
|
511,584
|
(1,291
|
)
|
|||||||
Total
adjustments
|
847,796
|
160,500
|
4,709,588
|
7,929,667
|
|||||||||
Net
cash used in operating activities
|
(2,939,372
|
)
|
(3,741,160
|
)
|
(7,740,377
|
)
|
(11,667,404
|
)
|
|||||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
|||||||||||||
Proceeds
from maturity of investments
|
-
|
-
|
295,000
|
300,000
|
|||||||||
Purchase
of investments
|
-
|
-
|
-
|
(250,000
|
)
|
||||||||
Proceeds
from sale of property and equipment
|
36,867
|
15,650
|
36,867
|
15,650
|
|||||||||
Purchases
of property and equipment
|
(206,976
|
)
|
(180,390
|
)
|
(1,008,639
|
)
|
(659,825
|
)
|
|||||
Payments
for patent costs
|
(320,724
|
)
|
(434,782
|
)
|
(986,924
|
)
|
(1,140,375
|
)
|
|||||
Net
cash used in investing activities
|
(490,833
|
)
|
(599,522
|
)
|
(1,663,696
|
)
|
(1,734,550
|
)
|
|||||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
|||||||||||||
Proceeds
from issuance of common stock
|
-
|
6,000
|
16,431,978
|
20,242,804
|
|||||||||
Net
cash provided by financing activities
|
-
|
6,000
|
16,431,978
|
20,242,804
|
|||||||||
NET
(DECREASE) INCREASE IN CASH AND CASH
EQUIVALENTS
|
(3,430,205
|
)
|
(4,334,682
|
)
|
7,027,905
|
6,840,850
|
|||||||
CASH
AND CASH EQUIVALENTS, beginning of period
|
20,731,745
|
17,610,433
|
10,273,635
|
6,434,901
|
|||||||||
CASH
AND CASH EQUIVALENTS, end of period
|
$
|
17,301,540
|
$
|
13,275,751
|
$
|
17,301,540
|
$
|
13,275,751
|
1. |
Description
of Business
|
2. |
Basis
of Presentation
|
3. |
Accounting
Policies
|
4. |
Consolidated
Statements of Cash Flows
|
5. |
Accounting
for Stock-Based Compensation
|
Three
months ended
September
30,
|
Nine
months ended
September
30,
|
||||||||||||
2006
|
2005
|
2006
|
2005
|
||||||||||
Research
and development expense
|
$
|
201,159
|
$
|
-
|
$
|
697,673
|
$
|
-
|
|||||
Sales
and marketing expense
|
72,705
|
-
|
261,261
|
-
|
|||||||||
General
and administrative expense
|
161,736
|
229,150
|
962,939
|
658,300
|
|||||||||
Total
share-based expense
|
$
|
435,600
|
$
|
229,150
|
$
|
1,921,873
|
$
|
658,300
|
Nine
months ended
September
30, 2006
|
||||
Expected
option term (1)
|
4.25
to 7 years
|
|||
Expected
volatility factor (2)
|
69.48%
to 74.55
|
%
|
||
Risk-free
interest rate (3)
|
4.18%
to 4.78
|
%
|
||
Expected
annual dividend yield
|
0
|
%
|
(1)
|
The
expected term was determined based on historical activity for grants
with
similar terms and for similar groups of employees and represents
the
period of time that options are expected to be outstanding. For employee
options, groups of employees with similar historical exercise behavior
are
considered separately for valuation purposes. For directors and named
executive officers, the contractual term is used as the expected
term
based on historical behavior. In cases where there was not sufficient
historical information for grants with similar terms, the simplified,
or
“plain-vanilla” method of estimating option life was utilized.
|
(2)
|
The
stock volatility for each grant is measured using the weighted average
of
historical daily price changes of the Company’s common stock over the most
recent period equal to the expected option life of the grant.
|
(3)
|
The
risk-free interest rate for periods equal to the expected term of
the
share option is based on the U.S. Treasury yield curve in effect
at the
time of the grant.
|
Three
months ended
|
Nine
months ended
|
||||||
September
30, 2005
|
September
30, 2005
|
||||||
Net
loss, as reported
|
$
|
(3,901,660
|
)
|
$
|
(19,597,071
|
)
|
|
Stock-based
compensation expense that would have
been included in reported net loss
|
|
|
|
|
|||
if
the fair value provisions of SFAS No. 123 had been applied
to all awards
|
(1,958,207 |
)
|
(5,446,138 |
)
|
|||
Pro
forma net loss
|
$
|
(5,859,867
|
)
|
$
|
(25,043,209
|
)
|
|
Basic
and diluted net loss per share:
|
|||||||
As
reported
|
$
|
(0.19
|
)
|
$
|
(0.97
|
)
|
|
Proforma
|
$
|
(0.28
|
)
|
$
|
(1.24
|
)
|
Three
months ended
|
Nine
months ended
|
||||||
September
30, 2005
|
September
30, 2005
|
||||||
Expected
term
|
7
years
|
3
to 10 years
|
|||||
Expected
volatility
|
79
|
%
|
76.4%
to 81.9
|
%
|
|||
Risk
free interest rate
|
4.25
|
%
|
3.72%
to 4.25
|
%
|
|||
Dividend
yield
|
0
|
%
|
0
|
%
|
|
Shares
|
Weighted-Average
Exercise
Price
|
Weighted-Average
Remaining Contractual Term
|
Aggregate
Intrinsic Value ($)
|
|||||||||
Outstanding
at beginning of period
|
5,039,171
|
$
|
21.51
|
||||||||||
Granted
|
363,277
|
8.67
|
|||||||||||
Exercised
|
(29,000
|
)
|
6.38
|
$
|
108,925
|
||||||||
Forfeited
|
(82,958
|
)
|
9.64
|
||||||||||
Expired
|
(405,871
|
)
|
18.85
|
||||||||||
Outstanding
at end of period
|
4,884,619
|
$
|
21.09
|
4.25
years
|
$
|
1,321,677
|
|||||||
Exercisable
at end of period
|
4,187,037
|
$
|
23.39
|
3.89
years
|
$
|
709,418
|
Nonvested
Shares
|
|||||||
Shares
|
Weighted-Average
Grant-Date
Fair
Value
|
||||||
Nonvested
at January 1, 2006
|
656,498
|
$
|
5.01
|
||||
Granted
|
363,277
|
4.90
|
|||||
Vested
|
(265,985
|
)
|
6.25
|
||||
Forfeited
|
(56,208
|
)
|
5.40
|
||||
Nonvested
at September 30, 2006
|
697,582
|
$
|
4.45
|
|
Shares
|
Weighted-Average
Exercise
Price
|
Weighted-Average
Remaining Contractual Term
|
Aggregate
Intrinsic Value ($)
|
|||||||||
Outstanding
at beginning of period
|
1,977,401
|
$
|
30.29
|
||||||||||
Granted
|
593,335
|
8.50
|
|||||||||||
Exercised
|
-
|
-
|
-
|
||||||||||
Forfeited
|
-
|
-
|
|||||||||||
Expired
|
-
|
-
|
|||||||||||
Outstanding
at end of period
|
2,570,736
|
$
|
25.26
|
4.45
years
|
-
|
||||||||
Exercisable
at end of period
|
2,570,736
|
$
|
25.26
|
4.45
years
|
-
|
Nine
months ended
|
||||
September
30, 2006
|
||||
Expected
term
|
5
years
|
|||
Expected
volatility
|
80.33
|
%
|
||
Risk
free interest rate
|
4.5
|
%
|
||
Dividend
yield
|
0
|
%
|
6. |
Loss
per Share
|
7. |
Other
Assets
|
September
30, 2006
|
||||||||||
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
Value
|
||||||||
Patents
and copyrights
|
$
|
13,079,931
|
$
|
3,534,951
|
$
|
9,544,980
|
||||
Prepaid
licensing fees
|
705,000
|
558,500
|
146,500
|
|||||||
Deposits
and other
|
382,525
|
-
|
382,525
|
|||||||
$
|
14,167,456
|
$
|
4,093,451
|
$
|
10,074,005
|
December
31, 2005
|
||||||||||
Gross
Carrying Amount
(net
of impairment)
|
Accumulated
Amortization
|
Net
Value
|
||||||||
Patents
and copyrights
|
$
|
12,093,007
|
$
|
3,036,801
|
$
|
9,056,206
|
||||
Prepaid
licensing fees
|
705,000
|
415,250
|
289,750
|
|||||||
Deposits
and other
|
352,846
|
-
|
352,846
|
|||||||
$
|
13,150,853
|
$
|
3,452,051
|
$
|
9,698,802
|
8. |
Stock
Authorization and Issuance
|
9. |
Commitments
and Contingencies
|
10. |
Liquidity
and Capital Resources
|
11. |
Recent
Accounting Pronouncements
|
Date
of sale
|
Title
of security
|
Number
sold
|
Consideration
received and description of underwriting or other discounts to market
price afforded to purchasers
|
Exemption
from registration claimed
|
If
option, warrant or convertible security, terms of exercise or
conversion
|
|||||||||||
7/3/06
|
Options
to purchase common stock granted to an employee pursuant to the 2000
Plan
|
2,392
|
Option
granted - no consideration received by Company until exercised
|
4(2
|
)
|
Exercisable
for seven years from the grant date at an exercise price of $9.10
per
share.
|
||||||||||
7/13/06
|
Options
to purchase common stock granted to a consultant pursuant to the
2000
Plan
|
127,500
|
Option
granted - no consideration received by Company until
exercised
|
4(2
|
)
|
Options
vest upon completion of certain performance conditions and remain
exercisable for four years from the grant date at an exercise price
of $9.10 per share.
|
||||||||||
8/24/06
|
Options
to purchase common stock granted to an employee pursuant to the 2000
Plan
|
3,000
|
Option
granted - no consideration received by Company until exercised
|
4(2
|
)
|
Options
vest over three years and remain exercisable for seven years from
the
grant date at an exercise price
of $5.79 per share.
|
||||||||||
9/7/06
|
Options
to purchase common stock granted to directors pursuant to the 2000
Plan
|
90,000
|
Option
granted - no consideration received by Company until
exercised
|
4(2
|
)
|
Exercisable
for seven years from the date of grant at an exercise price of
$6.17
per share
|
Votes
Cast
|
|||||||
Name
|
For
|
Withheld
|
|||||
Jeffrey
Parker
|
17,968,998
|
2,197,122
|
|||||
Todd
Parker
|
15,658,783
|
4,507,337
|
|||||
David
Sorrells
|
15,660,008
|
4,506,112
|
|||||
William
Hightower
|
15,643,042
|
4,523,078
|
|||||
John
Metcalf
|
19,793,296
|
372,824
|
|||||
Robert
Sterne
|
17,950,042
|
2,216,078
|
|||||
Nam
Suh
|
19,791,329
|
374,791
|
|||||
William
Sammons
|
19,899,782
|
266,338
|
|||||
Papken
der Torossian
|
19,925,159
|
240,961
|
(a) |
Exhibits.
|
31.1 |
Section
302 Certification of Jeffrey L. Parker,
CEO
|
31.2 |
Section
302 Certification of Cynthia Poehlman,
CFO
|
32.1 |
Section
906 Certification
|
(b) |
Reports
on Form 8-K.
None.
|
ParkerVision, Inc. | ||
Registrant | ||
|
|
|
November 1, 2006 | By: | /s/Jeffrey L. Parker |
Jeffrey L. Parker | ||
Chairman and Chief Executive Officer |
November 1, 2006 | By: | /s/Cynthia L. Poehlman |
Cynthia L. Poehlman | ||
Chief Financial Officer |